Anti-CD101 Antibody

A rabbit polyclonal primary antibody from Antibodies.com targets human CD101, also known as IGSF2 or V7, a type I transmembrane glycoprotein of the immunoglobulin superfamily that is expressed on activated T lymphocytes, monocytes, granulocytes, dendritic cells, and select thymocyte subsets. The unconjugated reagent is validated for Western blot and ELISA workflows on human samples and is supplied as 100 µl of liquid.

Researchers apply this antibody to study CD101-mediated inhibitory signaling in T cells, activation thresholds in mucosal and peripheral immune compartments, and altered expression patterns associated with chronic inflammatory disease. The 100 µl vial format accommodates multiple immunoblots and plate-based assays, and aliquoting on first use preserves reagent activity across repeat experiments.